What to expect when you take Pregabalin and Oxybutynin?

Do you take Pregabalin and Oxybutynin? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Jan, 10, 2019

26,345 reports have been studied.


Females aged 50 to 59 :

18,848 related reports were analyzed:

Most common symptoms:

Dizziness
  • 7.17% for females aged 50 (±5) who take Pregabalin
Drowsiness
  • 5.43% for females aged 50 (±5) who take Pregabalin
Drug ineffective
  • 16.51% for females aged 50 (±5) who take Oxybutynin
  • 10.07% for females aged 50 (±5) who take Pregabalin
Fatigue
  • 6.34% for females aged 50 (±5) who take Pregabalin
  • 6.19% for females aged 50 (±5) who take Oxybutynin
Feeling abnormal
  • 5.06% for females aged 50 (±5) who take Pregabalin
Headache
  • 6.14% for females aged 50 (±5) who take Pregabalin
Insomnia
  • 5.02% for females aged 50 (±5) who take Pregabalin
Malaise
  • 5.83% for females aged 50 (±5) who take Pregabalin
Nausea
  • 6.16% for females aged 50 (±5) who take Pregabalin
Pain
  • 14.84% for females aged 50 (±5) who take Pregabalin
Pain in extremity
  • 6.07% for females aged 50 (±5) who take Pregabalin
Rashes
  • 5.58% for females aged 50 (±5) who take Oxybutynin
Urinary tract infection
  • 5.35% for females aged 50 (±5) who take Oxybutynin
Weight increased
  • 7.01% for females aged 50 (±5) who take Pregabalin

Most common co-existing conditions:

Depression
  • 9.56% for females aged 50 (±5) who take Pregabalin
Gait disturbance
  • 6.57% for females aged 50 (±5) who take Oxybutynin
Gastroesophageal reflux disease
  • 5.05% for females aged 50 (±5) who take Oxybutynin
High blood cholesterol
  • 5.85% for females aged 50 (±5) who take Pregabalin
High blood pressure
  • 8.91% for females aged 50 (±5) who take Pregabalin
  • 5.35% for females aged 50 (±5) who take Oxybutynin
Hypertonic bladder
  • 11.85% for females aged 50 (±5) who take Oxybutynin
Multiple sclerosis
  • 21.41% for females aged 50 (±5) who take Oxybutynin
  • 5.15% for females aged 50 (±5) who take Pregabalin
Neuropathy peripheral
  • 7.78% for females aged 50 (±5) who take Pregabalin
Pain
  • 16.7% for females aged 50 (±5) who take Pregabalin
  • 5.35% for females aged 50 (±5) who take Oxybutynin
Pollakiuria
  • 6.8% for females aged 50 (±5) who take Oxybutynin
Rheumatoid arthritis
  • 6.42% for females aged 50 (±5) who take Pregabalin
Stress and anxiety
  • 6.31% for females aged 50 (±5) who take Pregabalin
Urinary incontinence
  • 5.73% for females aged 50 (±5) who take Oxybutynin
back to top

Males aged 50 to 59 :

7,497 related reports were analyzed:

Most common symptoms:

Confusional state
  • 5.0% for males aged 50 (±5) who take Oxybutynin
Diarrhea
  • 7.22% for males aged 50 (±5) who take Oxybutynin
Dizziness
  • 5.36% for males aged 50 (±5) who take Pregabalin
Drug ineffective
  • 9.44% for males aged 50 (±5) who take Oxybutynin
  • 9.4% for males aged 50 (±5) who take Pregabalin
Fall
  • 10.56% for males aged 50 (±5) who take Oxybutynin
Fatigue
  • 10.56% for males aged 50 (±5) who take Oxybutynin
  • 5.15% for males aged 50 (±5) who take Pregabalin
Multiple sclerosis relapse
  • 5.0% for males aged 50 (±5) who take Oxybutynin
Muscle spasms
  • 5.0% for males aged 50 (±5) who take Oxybutynin
Pain
  • 10.41% for males aged 50 (±5) who take Pregabalin
  • 5.0% for males aged 50 (±5) who take Oxybutynin
Rashes
  • 6.11% for males aged 50 (±5) who take Oxybutynin
Urinary tract infection
  • 13.89% for males aged 50 (±5) who take Oxybutynin
Weakness
  • 11.11% for males aged 50 (±5) who take Oxybutynin

Most common co-existing conditions:

Depression
  • 5.89% for males aged 50 (±5) who take Pregabalin
Diabetes
  • 6.67% for males aged 50 (±5) who take Oxybutynin
  • 6.33% for males aged 50 (±5) who take Pregabalin
Diabetic neuropathy
  • 6.2% for males aged 50 (±5) who take Pregabalin
Gait disturbance
  • 7.78% for males aged 50 (±5) who take Oxybutynin
High blood cholesterol
  • 7.22% for males aged 50 (±5) who take Oxybutynin
  • 5.36% for males aged 50 (±5) who take Pregabalin
High blood pressure
  • 11.11% for males aged 50 (±5) who take Oxybutynin
  • 9.76% for males aged 50 (±5) who take Pregabalin
Multiple sclerosis
  • 27.78% for males aged 50 (±5) who take Oxybutynin
Neuropathy peripheral
  • 10.48% for males aged 50 (±5) who take Pregabalin
Pain
  • 17.75% for males aged 50 (±5) who take Pregabalin
  • 6.67% for males aged 50 (±5) who take Oxybutynin
Sleep disorder
  • 5.0% for males aged 50 (±5) who take Oxybutynin
back to top

Do you take Pregabalin and Oxybutynin:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

Pregabalin

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. (latest outcomes from Pregabalin 18,616 users)

Oxybutynin

Oxybutynin has active ingredients of oxybutynin. It is often used in urge incontinence. (latest outcomes from Oxybutynin 9,598 users)

General study

Related publications that referenced our studies


Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!